Hematology

The CGTLive™ Hematology specialty topic page houses the most up-to-date clinical news coverage in the field of hematology gene and cell therapy. It also includes video interviews with key opinion leaders in the field of hematology/oncology about the latest relevant FDA actions, clinical guideline updates, and clinical trial findings related to the development of cell therapies, gene therapies, and engineered and regenerative medicines for various blood disorders.

Latest News

CGTLive®’s Weekly Rewind
CGTLive®’s Weekly Rewind – November 8, 2024

November 8th 2024

Review top news and interview highlights from the week ending November 8, 2024.

Danny M. Cohn, MD, PhD, a staff vascular medicine specialist at Amsterdam University Medical Center
NTLA-2002 Gene Editing Reduces Angioedema Attacks in Hereditary Angioedema

November 8th 2024

Around the Helix: Cell and Gene Therapy Company Updates – November 6, 2024
Around the Helix: Cell and Gene Therapy Company Updates – November 6, 2024

November 6th 2024

Caroline Diorio, MD, FRCPC, FAAP, an attending physician at the Cancer Center at Children's Hospital of Philadelphia
Noninflammatory Neurotoxicity Events in Patients Receiving CAR-T

November 5th 2024

FDA Activity Recap: October 2024 Features IND Clearances and Company Alignment on Plans in FDA Meetings
FDA Activity Recap: October 2024 Features IND Clearances and Company Alignment on Plans in FDA Meetings

November 4th 2024

Latest CME Events & Activities

Community Oncology Connections™: Overcoming Clinical Challenges and Embracing New Opportunities in the Management of Multiple Myeloma

View More

Exploring the Dynamic Shifts in the MDS Treatment Paradigm: Unveiling Advances in Disease Modifying Therapies, Spotlight on Cutting-Edge Clinical Trials, and the Latest Approvals

View More

Cases and Conversations™: Applying Guidelines to Practice for the Management of Paroxysmal Nocturnal Hemoglobinuria

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Oncology Briefings™: Selecting Therapy for Patients with Heavily Pretreated Myeloma Based on Patient and Disease-Specific Factors

View More

Oncology Briefings™: Case Discussions in Smoldering Myeloma—To Treat or Not to Treat?

View More

Medical Crossfire®: How Has the Nurse’s Role Evolved in the Management of Pediatric Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas?

View More

Community Practice Connections™: How Can We Optimize the Real World Application of BCMA-Targeted Therapies for Our Patients with R/R Multiple Myeloma?

View More

Annual Hematology Meeting: Preceding the 66th ASH Annual Meeting and Exposition

December 6, 2024

Register Now!

Navigating the Next Wave in BTK Inhibition Strategies: Maximizing Clinical Benefit in CLL and MCL, What’s Next...

December 14, 2024

Register Now!

Oncology Town Hall™: Primary Investigators Present Key Abstracts in CLL from San Diego

View More

Understanding the Recent Developments in Myelodysplastic Syndromes (MDS)

View More

Focusing on Key Updates on the Outlook of Acute Lymphocytic Leukemia (ALL) Management

View More

Experts Address the Hottest Topics in AML: Considerations on FLT3, IDH1/2, TP53, Maintenance, Novel Combinations and Beyond!

View More

Medical Crossfire®: Novel BTKi Strategies Transforming Aggressive and Indolent B-Cell Malignancies

View More

Medical Crossfire®: Bridging Expert Guidance and Evidence-Based Recommendations in the Treatment of AYA and Adult ALL

View More

Translating New Evidence into Treatment Algorithms from Frontline to R/R Multiple Myeloma: How the Experts Think & Treat

View More

Putting Your Stamp on the Next Generation of Care in CML — Improving Outcomes from Frontline to R/R Treatment Settings

View More

Medical Crossfire: How Has Iron Supplementation Altered Treatment Planning for Patients with Cancer-Related Anemia?

View More

How Do We Treat GVHD Today…And Tomorrow? Treatment Algorithms for Key Decision Points in Prophylaxis Care, Acute, and Chronic Disease

View More

Real-World Applications of Asparaginase Formulations in ALL and LBL From Pediatric/AYA to Adult Treatment: Maximizing Clinical Benefits Through Multidisciplinary Care

View More

The Latest Advancements in the Treatment of Chronic Myeloid Leukemia (CML)

View More

The Effect of Recent Updates on the Outlook of Acute Myeloid Leukemia (AML) Management

View More

Experts Address the Hottest Topics in AML: Considerations on FLT3, IDH1/2, TP53, Maintenance, Novel Combinations and Beyond!

View More

How We Do It®: Novel Biologic Strategies Reshaping Treatment Decision-Making in Pediatric to Adult Hodgkin Lymphoma

View More

Medical Crossfire®: Bridging Expert Guidance and Evidence-Based Recommendations in the Treatment of AYA and Adult ALL

View More

Medical Crossfire®: Novel BTKi Strategies Transforming Aggressive and Indolent B-Cell Malignancies

View More

Real-World Applications of Asparaginase Formulations in ALL and LBL From Pediatric/AYA to Adult Treatment: Maximizing Clinical Benefits Through Multidisciplinary Care

View More

Pediatric-Inspired Asparaginase Regimens for Patients With Acute Lymphocytic Leukemia

View More

29th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

February 27 - March 2, 2025

Register Now!

More News

© 2024 MJH Life Sciences

All rights reserved.